Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-2,451
Closed -$24.8K – 6841
2025
Q4
$24.8K Sell
2,451
-589
-19% -$8.36K ﹤0.01% 6329
2025
Q3
$38.9K Buy
3,040
+1,774
+140% +$23.1K ﹤0.01% 6195
2025
Q2
$12.8K Buy
+1,266
New +$14.5K ﹤0.01% 6001
2025
Q1
– Sell
-4,113
Closed -$74K – 6315
2024
Q4
$74K Sell
4,113
-16,351
-80% -$317K ﹤0.01% 5811
2024
Q3
$377K Sell
20,464
-6,672
-25% -$111K ﹤0.01% 5203
2024
Q2
$486K Buy
+27,136
New +$606K ﹤0.01% 4848

Other funds holding NVX

Goldman Sachs's NVX Position: Q1 2026 in Review

Goldman Sachs sold out of NOVONIX (NVX) in Q1 2026, closing a stake of 2,451 shares — an estimated $24.8K sold.

Goldman Sachs first reported a position in NVX in Q2 2024 and held it in 6 quarters. The position peaked at $486K in Q2 2024. 31 funds tracked by Wall St. Rank hold NVX as of Q1 2026.

  • Goldman Sachs reported no remaining NOVONIX position as of Q1 2026 after selling out during the quarter.
  • Goldman Sachs sold 2,451 NOVONIX shares in Q1 2026, an estimated $24.8K.
  • Goldman Sachs first reported a position in NOVONIX in Q2 2024 and held it in 6 quarters.
  • Goldman Sachs's NOVONIX position peaked at $486K in Q2 2024.
  • 31 funds tracked by Wall St. Rank held NOVONIX as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.